V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240011081 | 240007307 | 1.51 | 53 | Adjuvant (A) | 2014-05-28 | 2014-05-28 | Cisplatin + Radiotherapy | 02 | null | 240028136 | CISPLATIN + RT |
| 240011082 | 240007308 | 1.62 | 65.6 | Palliative (P) | 2013-10-22 | 2013-10-23 | Carboplatin + Paclitaxel (3 weekly) | N | N | 240028138 | CARBOPLATIN + PACLITAXEL |
| 240011083 | 240007309 | 1.65 | 67 | Disease modification (D) | 2017-12-12 | 2018-01-14 | CARBOPLATIN + PACLITAXEL | N | N | 240028146 | CARBOPLATIN + PACLITAXEL |
| 240011084 | 240011937 | 1.75 | 74 | Palliative (P) | 2016-02-22 | 2016-06-04 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240028147 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240011085 | 240007311 | 1.76 | 67 | Neo-adjuvant (N) | 2018-02-27 | 2018-03-18 | CVP R | N | N | 240028155 | CVP R |
| 240011086 | 240011938 | 1.66 | 100.3 | Adjuvant (A) | 2013-10-05 | 2013-10-26 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 240028155 | CARBOPLATIN + PACLITAXEL |
| 240011087 | 240007312 | 1.61 | null | Palliative (P) | 2017-06-15 | 2017-11-15 | Bevacizumab + CARBOPLATIN + PACLITAXEL | null | N | 240028169 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240011088 | 240007313 | 1.6 | null | Palliative (P) | 2017-10-01 | 2017-10-31 | CARBOPLATIN + PACLITAXEL | N | N | 240028174 | CARBOPLATIN + PACLITAXEL |
| 240011089 | 240007314 | 1.64 | 67.4 | Curative (C) | 2015-06-15 | 2015-07-06 | CVP R | N | N | 240028175 | CVP R |
| 240011090 | 240007316 | 1.59 | 54.5 | Palliative (P) | 2018-04-11 | 2018-05-02 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240028191 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240011091 | 240007318 | 1.66 | null | Not known (9) | 2015-03-14 | 2015-03-14 | CARBOPLATIN + PACLITAXEL | N | N | 240028193 | CARBOPLATIN + PACLITAXEL |
| 240011092 | 240007319 | 1.65 | 53.5 | Palliative (P) | 2016-02-20 | 2016-05-09 | Carboplatin + Paclitaxel (3 weekly) | N | N | 240028199 | CARBOPLATIN + PACLITAXEL |
| 240011093 | 240011940 | 1.62 | 65.3 | Curative (C) | 2017-12-11 | 2017-12-25 | Cisplatin + Radiotherapy | 02 | null | 240028202 | CISPLATIN + RT |
| 240011094 | 240014121 | 1.92 | 49 | null | 2014-07-02 | 2014-10-14 | CISPLATIN + RT | N | N | 240028204 | CISPLATIN + RT |
| 240011095 | 240015225 | null | 112.7 | Palliative (P) | 2017-10-09 | 2017-10-23 | Carboplatin + Paclitaxel (3 weekly) | N | N | 240028206 | CARBOPLATIN + PACLITAXEL |
| 240011096 | 240015225 | 1.79 | 94 | Palliative (P) | 2017-06-03 | 2017-06-18 | CVP R | 02 | null | 240028206 | CVP R |
| 240011097 | 240011941 | 1.75 | 65.3 | Palliative (P) | 2018-11-18 | 2018-11-18 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 240028216 | CARBOPLATIN + PACLITAXEL |
| 240011098 | 240011941 | 1.69 | 73.3 | Palliative (P) | 2015-04-06 | 2015-04-18 | CVP R | N | null | 240028216 | CVP R |
| 240011099 | 240011942 | 1.77 | 80.8 | Adjuvant (A) | 2018-04-23 | 2018-05-30 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240028228 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240011100 | 240014123 | 1.6 | 47.1 | Not known (9) | 2016-01-24 | 2016-01-24 | Cisplatin + Radiotherapy | N | N | 240028228 | CISPLATIN + RT |
| 240011101 | 240014123 | 1.55 | 58.3 | Palliative (P) | 2015-06-08 | 2015-06-23 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240028228 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240011102 | 240007324 | 1.65 | 57.1 | Curative (C) | 2014-08-06 | 2014-08-10 | Cisplatin + Radiotherapy | N | N | 240028242 | CISPLATIN + RT |
| 240011103 | 240007326 | 1.63 | 84 | Palliative (P) | 2018-06-23 | 2018-06-23 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240028243 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240011104 | 240007329 | 1.72 | 89 | Neo-adjuvant (N) | 2018-07-08 | 2018-08-06 | R GCVP | null | null | 240028251 | CVP R |
| 240011105 | 240007329 | 1.68 | 73 | Palliative (P) | 2013-09-26 | 2013-10-18 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 240028251 | CARBOPLATIN + PACLITAXEL |
| 240011106 | 240014124 | 1.6 | 47 | Palliative (P) | 2019-04-30 | 2019-05-06 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 240028255 | CARBOPLATIN + PACLITAXEL |
| 240011107 | 240015227 | 1.52 | 76 | Neo-adjuvant (N) | 2014-10-07 | 2014-11-03 | CISPLATIN + RT | 2 | Y | 240028262 | CISPLATIN + RT |
| 240011108 | 240007330 | 1.76 | null | Palliative (P) | 2013-10-16 | 2013-10-16 | Cisplatin + Radiotherapy | N | null | 240028281 | CISPLATIN + RT |
| 240011109 | 240011945 | 1.61 | 74 | Palliative (P) | 2017-11-03 | 2017-11-28 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240028284 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240011110 | 240014125 | 1.54 | 105 | Palliative (P) | 2016-01-14 | 2016-01-14 | CISPLATIN + RT | N | Y | 240028288 | CISPLATIN + RT |
| 240011111 | 240007332 | null | 110 | Palliative (P) | 2015-11-08 | 2015-11-23 | Carboplatin + Paclitaxel (3 weekly) | N | N | 240028296 | CARBOPLATIN + PACLITAXEL |
| 240011112 | 240007334 | 1.6 | 66 | Neo-adjuvant (N) | 2017-04-09 | 2017-04-10 | CVP R | 2 | N | 240028298 | CVP R |
| 240011113 | 240007334 | 0 | 52.3 | Curative (C) | 2017-02-27 | 2017-06-05 | CVP R | N | null | 240028298 | CVP R |
| 240011114 | 240011947 | 1.69 | 68.2 | Curative (C) | 2014-08-31 | 2014-09-02 | Cisplatin + Radiotherapy | N | Y | 240028305 | CISPLATIN + RT |
| 240011115 | 240011947 | 1.67 | 62.8 | Palliative (P) | 2015-11-26 | 2015-11-26 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240028305 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240011116 | 240014127 | 1.66 | 53 | null | 2017-07-04 | 2017-07-04 | Cisplatin + Radiotherapy | 02 | null | 240028332 | CISPLATIN + RT |
| 240011117 | 240014127 | 1.65 | 69.4 | Palliative (P) | 2017-08-10 | 2017-08-11 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240028332 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240011118 | 240007339 | 1.62 | 54.5 | Adjuvant (A) | 2018-05-30 | 2018-06-03 | CVP R | 02 | null | 240028358 | CVP R |
| 240011119 | 240007340 | 1.68 | 58 | Palliative (P) | 2018-01-04 | 2018-01-15 | CARBOPLATIN + PACLITAXEL | N | N | 240028362 | CARBOPLATIN + PACLITAXEL |
| 240011120 | 240007341 | 1.68 | 89.6 | null | 2018-06-08 | 2018-06-13 | Cisplatin + Radiotherapy | 02 | Y | 240028372 | CISPLATIN + RT |
| 240011121 | 240007344 | null | 111 | Neo-adjuvant (N) | 2014-08-05 | 2014-09-04 | CARBOPLATIN + PACLITAXEL | null | Y | 240028374 | CARBOPLATIN + PACLITAXEL |
| 240011122 | 240014128 | 1.83 | 63.4 | Palliative (P) | 2014-07-04 | 2014-08-31 | Carboplatin + Paclitaxel (3 weekly) | null | N | 240028375 | CARBOPLATIN + PACLITAXEL |
| 240011123 | 240007345 | 1.57 | null | Curative (C) | 2013-03-23 | 2013-04-06 | Cisplatin + Radiotherapy | N | Y | 240028383 | CISPLATIN + RT |
| 240011124 | 240011950 | 1.67 | null | Palliative (P) | 2015-10-05 | 2015-10-05 | CARBOPLATIN + PACLITAXEL | N | N | 240028397 | CARBOPLATIN + PACLITAXEL |
| 240011125 | 240007348 | 1.53 | null | Palliative (P) | 2017-07-29 | 2017-10-21 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | null | 240028402 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240011126 | 240007349 | 1.62 | null | Neo-adjuvant (N) | 2016-05-11 | 2016-05-21 | Cisplatin + Radiotherapy | N | N | 240028414 | CISPLATIN + RT |
| 240011127 | 240011952 | 1.57 | 68 | Palliative (P) | 2014-02-18 | 2014-03-11 | CVP R | 02 | N | 240028417 | CVP R |
| 240011128 | 240014130 | 1.67 | null | Adjuvant (A) | null | 2016-07-15 | CARBOPLATIN + PACLITAXEL | null | N | 240028417 | CARBOPLATIN + PACLITAXEL |
| 240011129 | 240007350 | 1.84 | 72.3 | Palliative (P) | 2014-09-12 | 2014-09-24 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240028431 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240011130 | 240011953 | 1.7 | 94.6 | Palliative (P) | 2014-12-18 | 2016-04-25 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 240028436 | CARBOPLATIN + PACLITAXEL |